Archives for: January 30th, 2019

CORMEDIX INC. ANNOUNCES TOPLINE ANALYSIS OF THE FULL DATA SET OF PHASE 3 LOCK-IT-100 STUDY REINFORCES THE INTERIM RESULTS

Written by Sam Nelson on January 30, 2019

Berkeley Heights, NJ – January 30, 2019 – CorMedix Inc. (NYSE…

CORMEDIX INC. ANNOUNCES HIGHLY STATISTICALLY SIGNIFICANT TOPLINE RESULTS FOR NEUTROLIN® FROM THE INTERIM ANALYSIS OF THE PHASE 3 LOCK-IT-100 STUDY

Written by Sam Nelson on January 17, 2019

Conference Call today at 4:30 p.m. Eastern Time Berkeley Heights,…

CORMEDIX INC. ANNOUNCES RESIGNATION OF MEMBER OF ITS BOARD OF DIRECTORS

Written by Sam Nelson on January 17, 2019

Berkeley Heights, NJ – January 16, 2019 – CorMedix Inc….

CORMEDIX ANNOUNCES CLOSING OF $7.5 MILLION SENIOR SECURED CONVERTIBLE DEBT FINANCING

Written by Sam Nelson on January 7, 2019

Berkeley Heights, NJ – January 3, 2019 – CorMedix Inc. (NYSE…